Electronic devices and their highly integrated components formed from semiconductor crystals contain complex three-dimensional (3D) arrangements of elements and wiring. Photonic crystals, being analogous to semiconductor crystals, are expected to require a 3D structure to form successful optoelectronic devices. Here, we report a novel fabrication technology for a semiconductor 3D photonic crystal by uniting integrated circuit processing technology with micromanipulation. Four- to twenty-layered (five periods) crystals, including one with a controlled defect, for infrared wavelengths of 3-4.5 microm, were integrated at predetermined positions on a chip (structural error <50 nm). Numerical calculations revealed that a transmission peak observed at the upper frequency edge of the bandgap originated from the excitation of a resonant guided mode in the defective layers. Despite their importance, detailed discussions on the defective modes of 3D photonic crystals for such short wavelengths have not been reported before. This technology offers great potential for the production of optical wavelength photonic crystal devices.
SummaryRecent studies have investigated how defined peptides influence T cell development. Using a T cell receptor-transgenic [32-microglobulin--deficient model, we have examined T cell maturation in fetal thymic organ cultures in the presence of various peptides containing single-alanine substitutions of the strong peptide agonist, p33. Cocultivation with the peptide A4Y, which contains an altered T cell contact residue, resulted in efficient positive selection. Several in vitro assays demonstrated that A4Y was a moderate agonist relative to p33. Although A4Y promoted positive selection over a wide concentration range, high doses of this peptide could not induce clonal deletion. Thymocytes maturing in the presence of A4Y were no longer able to respond to A4Y, but could proliferate against p33. These studies demonstrate that (a) peptides that induce eflficient positive selection at high concentrations are not exclusively antagonists; (b) some agonists do not promote clonal deletion; (c) positive selection requires a unique T cell receptor-peptide-major histocompatibility complex interaction; and (d) interactions with selecting peptides during T cell ontogeny may define the functional reactivity of mature T cells. T CRs expressed on maturing thymocytes interact withpeptide-MHC complexes on thymic stromal cells and transmit signals that lead to either positive or negative T cell selection (1-3). Positive selection is an active process that rescues self-MHC-restricted thymocytes from programmed cell death. In contrast, negative selection tolerizes potentially autoreactive T cells, either through clonal deletion or unresponsiveness. Clonal deletion physically removes thymocytes by inducing apoptosis, as compared with unresponsiveness, which modifies developing T cells so that they can no longer respond against the tolerizing antigen. Since positive and negative selection shape the TCR repertoire and define the basis of self-/non-self-antigens, much research has focused on understanding T cell development. Studies have addressed how clonotypic TCRs expressed on CD4+CD8 + double-positive thymocytes can distinguish between these two selection events. Although it has been demonstrated that peptides are involved in positive and negative selection (4, 5), it remains controversial whether the selecting ligand has a qualitative or quantitative role in determining the fate of the developing T cell.Recently, altered peptide ligands have been identified that can inhibit some or all mature T cell effector functions (6-10). Antagonist peptides are defined as ligands that engage TCRs and actively inhibit biological responses. Partial agonists are closely related peptides that stimulate a subset ofT cell effector functions (11). This is in contrast with agonist peptides, which induce a complete range ofT cell responses. Studies by Hogquist et al. (12,13) and Jameson et al. (14) showed a correlation between peptide antagonists and positive selection. These results suggest that a positively selecting peptide is qualitatively diffe...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.